Envision Report

Published January 8, 2018

Spain Over-the-Counter (OTC) Drugs Market – Share, Outlook, Trends, Size and Forecasts (2018 – 2024)

Download Free Sample Report!

The Spain OTC drugs market was valued at USD XX million in 2018 and is projected to reach a value of USD XX million by 2024, registering a CAGR of XX%, during the forecast period 2018-2024. Over-the-counter(OTC) medicine is also known as OTC or nonprescription medicine. All these terms refer to that medicine because you can buy without a prescription. They are safe and effective when you follow the directions on the label and as directed by your healthcare professional.

Spain Over-the-Counter (OTC) Drugs Market Share:

Compared to the past years, Over-the-Counter devices have undergone a predominant change in the markets of Spain. The Product Type segment is expected to have the highest growth rate.

Spain Over-the-Counter (OTC) Drugs Market Size:

There is the full range of Products in Over-the-Counter Drugs Market such as Cough and Cold, Vitamin, Minerals and Supplements, Analgesics, and Digestive Products. As there are significant applications, the market size related to OTC is, even more, more prominent in  Spain.

Spain Over-the-Counter (OTC) Drugs Market Growth:

Product Innovation, Increasing distribution channels for OTC drugs, Pharmaceutical companies switching to OTC from Rx drugs, Ease in advertising restrictions for these OTC drugs are significant factors that propel or drive the growth of  Spain Over-the-Counter(OTC) Drugs market.

Spain Over-the-Counter (OTC) Drugs Market Industry Analysis:

The Spain Over-the-Counter Drugs market has been segmented by product type, which is sub-segmented into digestive products, vitamins, minerals and supplements, analgesics, cough and cold, and others.

Spain Over-the-Counter (OTC) Drugs Market Outlook:

Incorrect self-diagnosis and Concerns regarding the probability of substance abuse of OTC drugs are the two major factors responsible for the hampering of the OTC market growth.

Spain Over-the-Counter (OTC) Drugs Market Trends:

Takeda and Denali Therapeutics Collaborates to Develop and Commercialize Therapies for Neurodegenerative Diseases. MEDA launched a new product CB12.It is a powerful, unique and patented mouth rinse that ensures not only first-class breath but also provides a daily shot of confidence. Every day and all day CB12 offers 12 hours of protection.

Spain Over-the-Counter (OTC) Drugs Market Research report includes:

  • An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
  • To have complete market analysis through industry value chain analysisPorter’s fivePESTLESWOT analysis, and Y-o-Y analysis.
  • Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on YearOnYear
  • Identifying DROCin the current market and their impact in altering the market dynamics.
  • Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
  • Expertise investment opportunities by an analyst to the individual and organisation to have the better foothold in the market.
  • Identify the latest developments, market shares and strategies that are employed by the major market players, such as
  • Takeda Pharmaceutical Company Ltd.
  • GlaxoSmithKline PLC
  • Meda
  • Sanofi S.A.
  • Rovi Contract Manufacturing

Chapter 1 Introduction

1.1 Executive Summary

1.2 Market Definition

1.3 Scope of  the Study

Chapter 2 Research Methodology

2.1 Secondary Research

2.2 Primary Research

2.3 Analytic Tools and Model

2.4 Economic Indicator

2.4.1 Base Year, Base Currency, Forecasting Period

2.5 Expert Validation

2.6 Study Timeline

Chapter 3 Market Analysis

3.1 Industry Value Chain Analysis

3.2 Porter’s Five Analysis

3.2.1 Bargaining Power of Buyers

3.2.2 Bargaining Power of Suppliers

3.2.3 Threats of Substitutes

3.2.4 Threats of New Entrants

3.2.5 Industry Rivalry

3.3 Pestle Analysis

3.3.1 Political

3.3.2 Economical

3.3.3 Social

3.3.4 Technological

3.3.5 Legal

3.3.6 Environmental

3.4 SWOT Analysis

3.4.1 Strengths

3.4.2 Weakness

3.4.3 Opportunities

3.4.4 Threat

3.5 Y-O-Y Analyses

Chapter 4 Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

Chapter 5 Market Segmentation Analysis        

Chapter 6 Market Segmentation, By Product

     6.1 Cough and Cold

6.2 Analgesics

6.3 Vitamin, Minerals, and Supplements

6.4 Digestive Products                 

 Chapter 7 Market Segmentation, By Geography

7.1 Introduction

7.2 Spain

Chapter 8 Competitive Landscape

8.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements

8.2  Market Share Analysis

8.3 Strategies Adopted By Top Companies

Chapter 9 Company Profiles 

9.1. Johnson & Johnson

9.1.1. Company Overview

9.1.2. Financial Performance

9.1.3. Product Benchmarking

9.1.4. Strategic Initiative

9.2. Takeda Pharmaceutical Company Ltd.

9.3. Reckitt Benckiser Group PLC

9.4. GlaxoSmithKline PLC

9.5. Pfizer, Inc.

9.6. Sanofi S.A.

9.7. Bayer

9.8. Novartis International AG

9.9. Meda

9.10. Farmalider

9.11. Gebro

9.12. Alvogen

9.13. Rovi Contract Manufacturing

9.14. Grifols International, S.A.

Chapter 10 Market Estimates and Forecast

10.1 Market Estimates and Forecast 2018-2024(USD Million)

10.1.1 Market Estimation and Forecast by Type2018-2024 (USD Million)

10.1.2 Market Estimates and Forecast by Geography 2018-2024 (USD Million)

Chapter 11 Market Insights

11.1 Insights of Industry Experts

11.2 Analyst Opinion (Market Understanding)

11.3 Investment Opportunities

Chapter 12 Appendix

12.1 List of Tables

12.2 List of Figures

  • Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
  • Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
  • The Regional and Global Variety is taken care of in the report.
  • Year on Year basis generation of revenue is studied.
  • Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
  • The overview and the sustainability of the market are analyzed through SWOT.
  • DROC is recognized in the current market scenario and see how its effect on market dynamics.
  • The segment-level analysis in terms of type and technology.
  • The value chain analysis, value that's created and captured by a company is the profit margin.Value
  • Created and Captured – Cost of Creating that Value = Margin
  • An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
  • Basis on the depth of the study we approach using analytical tools
  • Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.


©2018 - Envision Inteligence | All Rights Reserved.